ursolic acid has been researched along with Atheroma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bernhard, D; Frotschnig, S; Huck, C; Laufer, G; Messner, B; Ploner, C; Ringer, T; Ritsch, A; Steinacher-Nigisch, A; Zeller, I | 1 |
| Tannock, LR | 1 |
2 other study(ies) available for ursolic acid and Atheroma
| Article | Year |
|---|---|
Ursolic acid causes DNA-damage, p53-mediated, mitochondria- and caspase-dependent human endothelial cell apoptosis, and accelerates atherosclerotic plaque formation in vivo.
Topics: Animals; Apolipoproteins E; Apoptosis; bcl-2 Homologous Antagonist-Killer Protein; bcl-X Protein; Caspases; Cell Proliferation; Cells, Cultured; Disease Models, Animal; DNA Damage; Dose-Response Relationship, Drug; Down-Regulation; Human Umbilical Vein Endothelial Cells; Humans; Hyperlipidemias; Interleukin-5; Male; Mice; Mice, Knockout; Mitochondria; Plaque, Atherosclerotic; RNA Interference; Time Factors; Transfection; Triterpenes; Tumor Suppressor Protein p53; Ursolic Acid | 2011 |
Ursolic acid effect on atherosclerosis: apples and apples, or apples and oranges?
Topics: Animals; Aortic Diseases; Apoptosis; Atherosclerosis; Cardiovascular Agents; Caspases; Diabetes Mellitus, Experimental; Diabetic Angiopathies; DNA Damage; Female; Human Umbilical Vein Endothelial Cells; Humans; Male; Mitochondria; Monocytes; Plaque, Atherosclerotic; Triterpenes; Tumor Suppressor Protein p53; Ursolic Acid | 2011 |